Dr. Hönle Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Markus Arendt

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

CEO

Markus Arendt

no data

Permanencia

Dr. Markus Arendt is Chairman of the Management Board of Dr. Hönle AG from May 01, 2024.

Dr. Hönle Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Dr. Hönle AG Announces Management Changes

Dr. Hönle AG, Annual General Meeting, Mar 23, 2023

Norbert Haimerl Becomes CEO of Dr. Hönle AG

Dr. Hönle AG, Annual General Meeting, Mar 24, 2022

Dr. Hönle AG, Annual General Meeting, Mar 23, 2021

Recent updates

Second quarter 2024 earnings released: EPS: €0.03 (vs €0.11 in 2Q 2023)

First quarter 2024 earnings released: €0.15 loss per share (vs €0.26 profit in 1Q 2023)

Price target decreased by 7.9% to €29.15

Dr. Hönle AG to Report Q1, 2024 Results on Feb 26, 2024

Dr. Hönle Ag Provides Earnings Guidance for the Year 2022/2023 and 2023/2024

Dr. Hönle AG Announces Management Changes

Dr. Hönle AG to Report Fiscal Year 2023 Results on Dec 07, 2023

New minor risk - Market cap size

Price target decreased by 14% to €31.65

Third quarter 2023 earnings released: €1.52 loss per share (vs €0.12 loss in 3Q 2022)

Now 22% undervalued

Second quarter 2023 earnings released: EPS: €0.11 (vs €0.36 in 2Q 2022)

Full year 2022 earnings released: €2.20 loss per share (vs €0.80 loss in FY 2021)

Dr. Hönle AG to Report Q3, 2023 Results on Aug 07, 2023

Dr. Hönle AG, Annual General Meeting, Mar 23, 2023

An unknown buyer acquired Raesch Quarz (Germany) GmbH from Dr. Hönle AG (XTRA:HNL).

Dr. Hönle AG to Report Fiscal Year 2022 Results on Dec 08, 2022

Norbert Haimerl Becomes CEO of Dr. Hönle AG

Third quarter 2022 earnings released: €0.12 loss per share (vs €0.021 profit in 3Q 2021)

Dr. Hönle AG Provides Earnings Guidance for 2022

Price target decreased to €44.75

Price target decreased to €57.00

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Dr. Hönle Ag Provides Earnings Guidance for 2022

Upcoming dividend of €0.20 per share

Dr. Hönle AG, Annual General Meeting, Mar 24, 2022

Price target decreased to €59.50

Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS €0.021 (vs €0.065 in 3Q 2020)

Second quarter 2021 earnings released

Upcoming Dividend of €0.50 Per Share

New 90-day low: €47.10

First quarter 2021 earnings released: EPS €0.27 (vs €0.48 in 1Q 2020)

Full year 2020 earnings released: EPS €1.02 (vs €2.24 in FY 2019)

Earnings beat expectations, revenue disappoints

Dr. Hönle AG to Report Fiscal Year 2020 Results on Jan 28, 2021

Dr. Hönle AG, Annual General Meeting, Mar 23, 2021

Dr. Hönle AG (XTRA:HNL) agreed to acquire STERILSYSTEMS GmbH.

Dr. Hönle Ag Withdraw its Earnings Guidance for the 2019-2020 Financial Year in April 2020

Earnings released

CEO

Permanencia